Annals of Hematology

, 89:105 | Cite as

Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

  • Donat Dürr
  • Raffaele Daniele Siciliano
  • Yvonne Hummel
  • Alix O’Meara
  • Anita Hirschi
  • Roger Burkhard
  • Hanspeter Honegger
Letter to the Editor

References

  1. 1.
    List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D et al (2005) Efficacy of lenalidomide in myelodysplastic syndrome. N Engl J Med 352(6):549–557CrossRefPubMedGoogle Scholar
  2. 2.
    Giagounidis A, Haase S, Heinsch M, Göhring G, Schlegelberger B, Aul C (2007) Lenalidomide in the context of complex karyotype of interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses. Ann Hematol 86:133–137CrossRefPubMedGoogle Scholar
  3. 3.
    Kelaidi C, Eclache V, Fenaux P (2008) The role of lenalidomide in the management of myelodysplasia with del 5q. Br J Hematol 140(3):267–278CrossRefGoogle Scholar
  4. 4.
    Giagounidis A, Fenaux P, Mufti GJ, Muus P, Platzbecker U, Sanz G et al (2008) Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes. Ann Hematol 87:345–352CrossRefPubMedGoogle Scholar
  5. 5.
    List A, Dewald G, Bennett J, Giagounidis A, Raza A, Feldman E et al (2006) Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med 355(14):1456–1465CrossRefPubMedGoogle Scholar
  6. 6.
    Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ et al (2008) Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1-risk myelodysplastic syndromes with karyotypes other than deletion 5q. Blood 111:86–93CrossRefPubMedGoogle Scholar
  7. 7.
    Mohr B, Oelschlaegel U, Thiede C, Stewart MM, Ehninger G, Platzbecker U (2009) The response to lenalidomide of myelodysplastic syndrome patients with deletion del (5q) can be sequentially monitored in CD34+ progentior cells. Haematologica 94:430–431. doi:10.3324/haematol13865 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Donat Dürr
    • 1
  • Raffaele Daniele Siciliano
    • 1
  • Yvonne Hummel
    • 1
  • Alix O’Meara
    • 1
  • Anita Hirschi
    • 1
  • Roger Burkhard
    • 1
  • Hanspeter Honegger
    • 1
  1. 1.Medical OncologyStadtspital TriemliZurichSwitzerland

Personalised recommendations